Oncotarget

Research Papers:

A mechanism for 1,4-Benzoquinone-induced genotoxicity

Mi Young Son _, Chu-Xia Deng, Jan H. Hoeijmarkers, Vivienne I. Rebel and Paul Hasty

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:46433-46447. https://doi.org/10.18632/oncotarget.10184

Metrics: PDF 1474 views  |   HTML 2208 views  |   ?  


Abstract

Mi Young Son1, Chu-Xia Deng2, Jan H. Hoeijmarkers3, Vivienne I. Rebel4,5,6,7,8, Paul Hasty1,5,6

1Department of Molecular Medicine and Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

2Faculty of Health Sciences, University of Macau, Macau SAR China

3Department of Genetics, Cancer Genomics Netherlands, Erasmus MC, The Netherlands

4Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

5The Cancer Therapy Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

6The Barshop Center of Aging, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

7Greehey Children’s Cancer Research Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

8Current address: BioAffinity, San Antonio, Texas, USA

Correspondence to:

Paul Hasty, email: hastye@uthscsa.edu

Keywords: Fanconi anemia, double strand break repair, replication fork maintenance, type 1 topoisomerase

Received: April 18, 2016    Accepted: May 22, 2016    Published: June 20, 2016

ABSTRACT

Benzene is a common environmental toxin and its metabolite, 1-4-Benzoquinone (BQ) causes hematopoietic cancers like myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). BQ has not been comprehensively assessed for its impact on genome maintenance, limiting our understanding of the true health risks associated with benzene exposure and our ability to identify people with increased sensitivity to this genotoxin. Here we analyze the impact BQ exposure has on wild type and DNA repair-defective mouse embryonic stem (ES) cells and wild type human cells. We find that double strand break (DSB) repair and replication fork maintenance pathways including homologous recombination (HR) and Fanconi anemia (FA) suppress BQ toxicity. BQ-induced damage efficiently stalls replication forks, yet poorly induces ATR/DNA-PKCS responses. Furthermore, the pattern of BQ-induced γH2AX and 53BP1foci is consistent with the formation of poly(ADP-ribose) polymerase 1 (PARP1)-stabilized regressed replication forks. At a biochemical level, BQ inhibited topoisomerase 1 (topo1)-mediated DNA ligation and nicking in vitro; thus providing mechanism for the cellular phenotype. These data are consistent with a model that proposes BQ interferes with type I topoisomerase’s ability to maintain replication fork restart and progression leading to chromosomal instability that has the potential to cause hematopoietic cancers like MDS and AML.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 10184